• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷Rh2通过靶向CNNM1抑制前列腺癌血管生成。

Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1.

作者信息

Huang Yaqiang, Huang Hongxing, Han Zhaodong, Li Wei, Mai Zhipeng, Yuan Runqiang

机构信息

Department of Urology, Zhongshan City People's Hospital, Zhongshan 528400, China.

Department of Urology, Guangzhou First People's Hospital, Guangzhou 510180, China.

出版信息

J Nanosci Nanotechnol. 2019 Apr 1;19(4):1942-1950. doi: 10.1166/jnn.2019.16404.

DOI:10.1166/jnn.2019.16404
PMID:30486934
Abstract

To explore the molecular mechanism by which ginsenoside Rh2 (G-Rh2) inhibits prostate cancer by regulating vascular growth. Different concentrations of G-Rh2 with three prostate cancer cell lines (LNCaP, PC3 and DU145) were transplanted in nude mice, and tumor mass volume was measured over time. LNCaP, PC3 and DU145 were co-cultured with vascular endothelial cells to determine the optimal concentration of G-Rh2 by MTT assay. LNCaP, PC3 and DU145 were cultured under the selected concentration (0, 0.01, 0.05, 0.1, 0.5 and 1 mg/mL) of G-Rh2, and the expression levels of CD31, VEGF, PDGF and CNNM1 detected by qRT-PCR and western blot. The expression pattern of CD31 was detected in CNNM1 overexpressed and knockout LNCaP, PC3 and DU145 cells under G-Rh2. G-Rh2 significantly inhibited the growth of all three prostate cancer cell lines in the dorsum of nude mice ( <0.05), and the increment rate of vascular endothelial cells co-cultured with LNCaP, PC3 and DU145 ( <0.05). The expression of CD31, VEGF, PDGF and CNNM1 genes in LNCaP, PC3 and DU145 cells was inhibited by G-Rh2. Overexpression of CNNM1 reversed the inhibitory effect of G-Rh2 on the expression of CD31 in these cells ( <0.05), while the function of knockout of CNNM1 and the inhibitory effect of G-Rh2 appeared to be similar ( <0.05). In conclusion, G-Rh2 inhibited prostate cancer growth by inhibiting its angiogenesis through decreasing the expression of CNNM1 in the cancer cells.

摘要

探讨人参皂苷Rh2(G-Rh2)通过调节血管生成抑制前列腺癌的分子机制。将不同浓度的G-Rh2与三种前列腺癌细胞系(LNCaP、PC3和DU145)接种于裸鼠体内,随时间测量肿瘤体积。将LNCaP、PC3和DU145与血管内皮细胞共培养,通过MTT法确定G-Rh2的最佳浓度。将LNCaP、PC3和DU145在选定浓度(0、0.01、0.05、0.1、0.5和1mg/mL)的G-Rh2下培养,通过qRT-PCR和蛋白质印迹法检测CD31、VEGF、PDGF和CNNM1的表达水平。在G-Rh2作用下,检测CNNM1过表达和敲除的LNCaP、PC3和DU145细胞中CD31的表达模式。G-Rh2显著抑制裸鼠背部所有三种前列腺癌细胞系的生长(<0.05),以及与LNCaP、PC3和DU145共培养的血管内皮细胞的增殖率(<0.05)。G-Rh2抑制LNCaP、PC3和DU145细胞中CD31、VEGF、PDGF和CNNM1基因的表达。CNNM1的过表达逆转了G-Rh2对这些细胞中CD31表达的抑制作用(<0.05),而敲除CNNM1的作用与G-Rh2的抑制作用似乎相似(<0.05)。总之,G-Rh2通过降低癌细胞中CNNM1的表达抑制血管生成,从而抑制前列腺癌生长。

相似文献

1
Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1.人参皂苷Rh2通过靶向CNNM1抑制前列腺癌血管生成。
J Nanosci Nanotechnol. 2019 Apr 1;19(4):1942-1950. doi: 10.1166/jnn.2019.16404.
2
Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells.人参皂苷Rg3和Rh2对前列腺癌细胞增殖的影响。
Arch Pharm Res. 2004 Apr;27(4):429-35. doi: 10.1007/BF02980085.
3
Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.Rh2 或其苷元 APPT 联合多西他赛治疗前列腺癌。
Prostate. 2010 Sep 15;70(13):1437-47. doi: 10.1002/pros.21179.
4
Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models.在前列腺癌模型中,人参皂苷Rh2可协同增强紫杉醇或米托蒽醌的作用。
J Urol. 2006 May;175(5):1926-31. doi: 10.1016/S0022-5347(05)00891-8.
5
Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.一种新型人参皂苷Rh2纳米非离子表面活性剂囊泡制剂对前列腺癌增强抗肿瘤疗效的评估:一项体外研究。
Drug Des Devel Ther. 2020 Aug 13;14:3315-3324. doi: 10.2147/DDDT.S261027. eCollection 2020.
6
Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.通过人参皂苷 Rh2 调节肿瘤相关巨噬细胞与非小细胞肺癌之间的串扰,抑制肿瘤迁移和侵袭。
BMC Cancer. 2018 May 22;18(1):579. doi: 10.1186/s12885-018-4299-4.
7
Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.新型合成钠通道阻滞剂对前列腺癌细胞体外和体内抗癌及抗转移作用的评估。
Prostate. 2019 Jan;79(1):62-72. doi: 10.1002/pros.23711. Epub 2018 Sep 21.
8
Carnosol inhibits Hedgehog signaling pathway in both LNCaP and DU145 prostate cancer cell lines.鼠尾草酸可抑制LNCaP和DU145前列腺癌细胞系中的Hedgehog信号通路。
Cell Mol Biol (Noisy-le-grand). 2017 Aug 30;63(8):104-108. doi: 10.14715/cmb/2017.63.8.22.
9
Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines.瘦素对人正常前列腺和前列腺癌细胞系中瘦素受体同工型表达和增殖活性的影响。
Oncol Rep. 2018 Jan;39(1):182-192. doi: 10.3892/or.2017.6066. Epub 2017 Nov 1.
10
Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).单甲基化硒抑制LNCaP人前列腺癌异种移植物的生长,同时雄激素受体和前列腺特异性抗原(PSA)的表达降低。
Prostate. 2006 Jul 1;66(10):1070-5. doi: 10.1002/pros.20329.

引用本文的文献

1
Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosis.人参皂苷Rh2通过线粒体自噬和铁死亡诱导的线粒体损伤抑制前列腺癌的进展。
Front Oncol. 2025 Aug 21;15:1633891. doi: 10.3389/fonc.2025.1633891. eCollection 2025.
2
Ginsenoside Rh2 suppresses ferroptosis in ulcerative colitis by targeting specific protein 1 by upregulating microRNA-125a-5p.人参皂苷 Rh2 通过上调 microRNA-125a-5p 靶向特定蛋白 1 抑制溃疡性结肠炎中的铁死亡。
Eur J Med Res. 2024 Sep 2;29(1):450. doi: 10.1186/s40001-024-02025-w.
3
Human disease-related long noncoding RNAs: Impact of ginsenosides.
人类疾病相关的长链非编码RNA:人参皂苷的影响
J Ginseng Res. 2024 Jul;48(4):347-353. doi: 10.1016/j.jgr.2024.04.002. Epub 2024 Apr 14.
4
Synergistic Effect of Ginsenoside Rh2 Combines with Ionizing Radiation on CT26/ Colon Carcinoma Cells and Tumor-Bearing Animal Model.人参皂苷Rh2与电离辐射联合对CT26结肠癌细胞及荷瘤动物模型的协同作用
Pharmaceuticals (Basel). 2023 Aug 22;16(9):1188. doi: 10.3390/ph16091188.
5
Pharmacokinetics and pharmacodynamics of Rh2 and aPPD ginsenosides in prostate cancer: a drug interaction perspective.人参皂苷Rh2和aPPD在前列腺癌中的药代动力学和药效学:药物相互作用视角
Cancer Chemother Pharmacol. 2023 Dec;92(6):419-437. doi: 10.1007/s00280-023-04583-y. Epub 2023 Sep 15.
6
Structure Modification of Ginsenoside Rh and Cytostatic Activity on Cancer Cells.人参皂苷Rh的结构修饰及其对癌细胞的细胞抑制活性
ACS Omega. 2023 May 1;8(19):17245-17253. doi: 10.1021/acsomega.3c01665. eCollection 2023 May 16.
7
The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences and .人参皂苷Rh2抗癌的方式:分子证据及…… (原文最后似乎不完整)
J Ginseng Res. 2023 Mar;47(2):173-182. doi: 10.1016/j.jgr.2022.09.011. Epub 2022 Oct 6.
8
Ginsenoside Rh2 suppresses colon cancer growth by targeting the miR-150-3p/SRCIN1/Wnt axis.人参皂苷 Rh2 通过靶向 miR-150-3p/SRCIN1/Wnt 轴抑制结肠癌生长。
Acta Biochim Biophys Sin (Shanghai). 2023 Mar 14;55(4):633-648. doi: 10.3724/abbs.2023032.
9
Research progress of ginseng in the treatment of gastrointestinal cancers.人参在胃肠道癌症治疗中的研究进展
Front Pharmacol. 2022 Oct 12;13:1036498. doi: 10.3389/fphar.2022.1036498. eCollection 2022.
10
Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer.研究MCF7细胞中跳跃易位断点(JTB)蛋白表达下调的影响,以探讨其作为乳腺癌生物标志物的潜在用途。
Am J Cancer Res. 2022 Sep 15;12(9):4373-4398. eCollection 2022.